Watch our latest corporate film - chapter four
Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
See what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Our increased order book and solid financial and operational performance provide basis for future growth.
Play a key role in reaching the world's net zero targets.
By operating efficiently, delivering on our customer commitments and realising our strategic goals, we ensure long term success and sustainability.
Investors
We announced our results for the half year ended 30 June 2024 on 9 August 2024.
We provide our investors with information about our bonds, prospectuses, financial statements, credit ratings and taxation.
+44 (0)1753 660 660
investors@urenco.com